FAVA, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 4.415
EU - Europa 2.932
AS - Asia 981
SA - Sud America 109
AF - Africa 42
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 29
Totale 8.546
Nazione #
US - Stati Uniti d'America 4.348
IT - Italia 1.083
CN - Cina 533
IE - Irlanda 360
DE - Germania 253
FR - Francia 231
SE - Svezia 193
FI - Finlandia 135
GB - Regno Unito 107
PL - Polonia 98
IN - India 90
AT - Austria 89
KR - Corea 86
JP - Giappone 76
ES - Italia 63
UA - Ucraina 63
VN - Vietnam 53
BR - Brasile 47
CA - Canada 46
NL - Olanda 43
AU - Australia 35
TR - Turchia 35
EU - Europa 28
BE - Belgio 25
RU - Federazione Russa 25
NO - Norvegia 24
CH - Svizzera 23
SG - Singapore 23
AR - Argentina 22
RO - Romania 22
SN - Senegal 20
HK - Hong Kong 18
CL - Cile 17
GR - Grecia 15
MX - Messico 15
PE - Perù 15
DK - Danimarca 14
PT - Portogallo 13
TW - Taiwan 9
HU - Ungheria 8
SI - Slovenia 8
AM - Armenia 6
CO - Colombia 6
NG - Nigeria 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
ID - Indonesia 5
IR - Iran 5
LV - Lettonia 5
AL - Albania 4
HR - Croazia 4
KW - Kuwait 4
LK - Sri Lanka 4
RS - Serbia 4
TH - Thailandia 4
BG - Bulgaria 3
LB - Libano 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PA - Panama 3
QA - Qatar 3
TN - Tunisia 3
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
IL - Israele 2
LU - Lussemburgo 2
MN - Mongolia 2
MU - Mauritius 2
MY - Malesia 2
PH - Filippine 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
HN - Honduras 1
IS - Islanda 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
PK - Pakistan 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 8.546
Città #
Chandler 810
Dublin 359
Beijing 274
Fairfield 231
Ashburn 215
Torino 165
Houston 146
Wilmington 145
Woodbridge 143
Ann Arbor 115
Redwood City 113
Princeton 112
Medford 111
Villeurbanne 107
Nyköping 101
Seattle 100
Jacksonville 87
Vienna 85
Cambridge 81
Warsaw 72
Dearborn 70
Pisa 70
Milan 57
New York 49
Rome 45
Boston 34
Turin 30
Guangzhou 26
Washington 26
Tokyo 25
Dong Ket 24
Hebei 24
Pune 22
Hangzhou 20
Nanjing 20
Brussels 19
Fremont 18
Florence 16
Philadelphia 16
Shanghai 16
Hefei 15
Ottawa 15
Chengdu 14
Leiden 14
Santiago 14
Bologna 13
Kunming 13
Norwalk 12
Rochester 12
Istanbul 11
Silver Spring 11
São Paulo 11
Berlin 10
Duncan 10
Falls Church 10
Lima 10
Padova 10
Paris 10
Pavia 10
San Diego 10
Singapore 10
Amsterdam 9
Jinan 9
Madrid 9
Radomsko 9
Seoul 9
Baotou 8
Brescia 8
Genova 8
Saluzzo 8
Taipei 8
Toronto 8
Trondheim 8
Wuhan 8
Zurich 8
Hamburg 7
Helsinki 7
London 7
Mountain View 7
Pontevedra 7
Tianjin 7
Upper Marlboro 7
Zhengzhou 7
Abuja 6
Barcelona 6
Bergamo 6
Central 6
Charlestown 6
Munich 6
Nürnberg 6
Phoenix 6
Sydney 6
Verona 6
Bari 5
Boardman 5
Bordeaux 5
Buenos Aires 5
Como 5
Copenhagen 5
Jakarta 5
Totale 4.712
Nome #
Blood Flow Cytometry in Sézary Syndrome: New Insights on Prognostic Relevance and Immunophenotypic Changes During Follow-up. 428
Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre. 349
Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab 322
Spiky follicular mycosis fungoides: a clinicopathologic study of 8 cases. 291
Complete regression of melanoma skin metastases after electrochemotherapy plus ipilimumab treatment: An unusual clinical presentation 288
Intestinal involvement in toxic epidermal necrolysis. A case report and review of literature. 287
Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients. 281
Metastasi cutanee da melanoma: l’esperienza della I Clinica Dermatologica di Torino 278
Efficacia della fotochemioterapia extracorporea nel trattamento di un caso di lichen erosivo 252
Atopic dermatitis in a phenylketonuric untreated patient 247
Differences in clinicopathological features and distribution of risk factors in Italian melanoma patients 211
Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology group 203
HPyV6, HPyV7 and TSPyV DNA sequences detection in skin disease patients and healthy subjects. 200
Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model 199
Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas 198
High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease. 170
Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp 147
Halo nevi related to treatment with imatinib in a dermatofibrosarcoma protuberans patient 126
miR-155 expression in Primary Cutaneous T-Cell Lymphomas (CTCL) 126
Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study 120
Fotoferesi: applicazioni terapeutiche “off-label” 107
Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease. 103
Dermatofibrosarcoma protuberans: studio retrospettivo sui pazienti trattati negli ultimi 10 anni 100
Manifestazioni cutanee correlate al trattamento con imatinib mesilato in pazienti affetti da dermatofibrosarcoma protuberans 95
Treatment of metastatic melanoma: a multidisciplinary approach 87
BRAFi/MEKi in patients with metastatic melanoma: Predictive factors of complete response 81
Improvement of sensitivity in sentinel lymph node procedure in melanoma patients. 79
Arrhythmias in metastatic melanoma patient treated with targeted therapy and ICD implant. 78
Clonal heterogeneity in mycosis fungoides/Sézary Syndrome: incidence, relation with clinico-pathologic features and prognostic significance 75
Evaluation of PMNs functional and phenotypical alterations in mycosis fungoides patients. 75
Characterization and management of cutaneous side effects related to the immunosuppressive treatment in solid organ recipients 71
PCR Real time Mismatch Amplification Mutation Assay (MAMA Real Time PCR) for evaluation of TNFα promoter gene polymorphism -308 G/A in patients with psoriasis. 71
Bullous pemphigoid is characterised by a reduction of skin-homing/circulating FOXP3+ Tregs and by a down-regulation of the IL-10 pathway 70
Activity Of Imatinib Mesilate In Metastatic Melanoma 69
Cutaneous melanoma metastases arising on a split-skin graft donor site 68
TCRgamma-chain gene rearrangement by GeneScan: incidence and significance of clonal heterogeneity in Sézary syndrome. 67
Attività clinica e modulazione immunologica di bexarotene a basse dosi: presentazione di un caso 67
Progressione di malattia nei pazienti affetti da melanoma con linfonodo sentinella negativo 67
Radiotherapy and immune checkpoints inhibitors for advanced melanoma 67
After Surgery: Follow-Up Guidelines of Melanoma Patients 66
Immunotherapy in transplanted patients: A special population that can no longer be ignored 66
Zosteriform cutaneous metastases: a literature meta-analysis and a clinical report of three melanoma cases 64
Therapeutic approaches in advanced mycosis fungoides and Sezary Sindrome. A 30-year single institution experience 61
Gauze-based negative pressure wound therapy: a valid method to manage pyoderma gangrenosum? 61
Heterogeneity of Circulating CD4+ Memory T-Cell Subsets in Erythrodermic Patients: CD27 Analysis Can Help to Distinguish Cutaneous T-Cell Lymphomas from Inflammatory Erythroderma 60
TCRgamma-Chain Gene Rearrangement by PCR-Based GeneScan: Diagnostic Accuracy Improvement and Clonal Heterogeneity Analysis in Multiple Cutaneous T-Cell Lymphoma Samples 60
Th1, Th2, Th17 and Treg expression in cutaneous T-cell lymphoma patients: modulation of master gene targets. 60
Cutaneous Adverse Events Related To Treatment With Imatinib 59
CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study 59
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: Experience from an Italian skin cancer unit 54
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era 52
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study 52
Bexarotene as maintenance treatment after therapies other than skin-directed therapy in advanced-stage mycosis fungoides: a pilot study 51
Skin metastases of malignant melanoma: a clinical and prognostic survey 50
Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials 50
Disease progression in melanoma patients with negative sentinel lymph node: does false-negative specimens entirely account for this phenomenon? 49
From the Aosta valley to the Sicily it is Always melanoma but... Results of a multicentric Italian study from the GIPMe 49
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome 49
Folliculotropic Mycosis Fungoides: Current Guidance and Experience from Clinical Practice 47
Patologie cutanee in pazienti affetti da neoplasie ematologiche: studio osservazionale in 101 pazienti 46
Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: overview of the literature and clinical experience with long-term follow-up data 45
NEW PERSPECTIVES IN THE PHARMACOLOGICAL TREATMENT OF NON-MELANOMA SKIN CANCER 45
Infections in Sézary syndrome: A retrospective cohort study of 113 patients 45
Phenotype instability in Sézary cells: follow-up results in 107 patients 44
Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: A multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas. 44
Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients 44
Prognostic and predictive biomarkers in stage iii melanoma: Current insights and clinical implications 44
Therapeutic hotline. A rare vandetanib-induced photo-allergic drug eruption. 43
Melanoma management during the covid-19 pandemic emergency: A literature review and single-center experience 43
Clinical and pathological relevance of drug-induced vitiligo in patients treated for metastatic melanoma with anti-PD1 or BRAF/MEK inhibitors 43
A traveller's wart: tungiasis 42
HERV-E expression in peripheral mononuclear cells of patient with Psoriasis. 42
Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit 42
Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome? 42
Terapia adiuvante con interferone alte dosi modificato e sviluppo di vitiligine: descrizione di un caso 41
Mycosis Fungoides: disease evolution of the “lion queen” revisited. 39
Sezary syndrome: A single center retrospective study with proposal for a clinical score system 36
Epidemiology, Prevention and Clinical Diagnosis of Melanoma 36
Dermatological approach to vemurafenib skin toxicity: a single centre experience 35
Localizzazioni cutanee di patologia onco-ematologiche: presentazione di quadri clinici particolari 34
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives 34
Flow cytometric analyses of circulating regulatory T cells in patients with dermatitis herpetiformis and other immune mediated dermatoses. 33
Extracorporeal photopheresis in the treatment of erythrodermic cutaneous T-cell lymphoma: combination therapy results and long-term follow-up. 32
Un'insolita acropustolosi 32
Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study 31
Evolution of different clinical patterns of cutaneous lesions in a suspected COVID-19 patient 30
Predictive value of baseline [18f]fdg pet/ct for response to systemic therapy in patients with advanced melanoma 30
Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management 30
Guttate psoriasis in a patient with mycosis fungoides in treatment with Brentuximab vedotin: An unreported association 30
Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature. 29
Treatment of Advanced Metastatic Melanoma 29
Cutaneous metastases from malignant melanoma: clinical features and new therapeutic perspectives 28
Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study) 27
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19 27
Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System 26
Identification of risk factors for multiple non-melanoma skin cancers in italian kidney transplant recipients 25
Lack of detection of cutavirus DNA using PCR real time in Cutaneous T-cell Lymphomas (CTCL). 23
Real-life use of phototherapy in early-stage mycosis fungoides from the Cutaneous Lymphoma Commission of the Italian Lymphoma Foundation: Results of a web-based survey 20
Dramatic response of face desmoplastic melanoma after two doses of immunotherapy 17
Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience 17
Totale 8.764
Categoria #
all - tutte 23.631
article - articoli 0
book - libri 0
conference - conferenze 3.462
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.093


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019365 0 0 0 0 0 0 0 0 0 111 173 81
2019/20201.201 60 49 74 171 82 131 133 108 115 109 84 85
2020/2021686 76 43 49 41 63 74 48 33 56 59 53 91
2021/20221.145 60 44 48 62 129 55 53 55 35 68 253 283
2022/20232.040 225 194 61 173 170 421 125 200 257 47 120 47
2023/2024767 109 163 78 69 69 139 30 37 6 67 0 0
Totale 8.882